Remove companies oyster-point-pharma-inc
article thumbnail

Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris

Benzinga

Tender Offer to Acquire All Outstanding Shares of Oyster Point Pharma for $11.00 07, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. NASDAQ: OYST ), ("Oyster Point Pharma"), today announced that it has entered into a definitive agreement under which Viatris Inc.

Finance 40
article thumbnail

Cravath-Led Viatris Unveils Ophthalmology Buys Worth $750M

Law 360 M&A

Health care company Viatris Inc. announced on Monday that it had reached agreements to purchase Oyster Point Pharma and Famy Life Sciences in order to create an ophthalmology franchise, with guidance from Cravath Swaine & Moore LLP.

40